Androgenic alopeciahttps://en.wikipedia.org/wiki/Pattern_hair_loss
Androgenic alopecia bụ ụdị ntutu isi na-emetụta isi na ihu. N'ụdị ntutu isi nwoke (MPHL), ntutu isi na-egosipụtakarị dị ka ntutu isi na-ala azụ, ntutu na-apụ n'elu vertex, ma ọ bụ ngwakọta nke ha abụọ. Ụdị ntutu isi nwanyị (FPHL) na-egosipụtakarị dị ka mkpụmkpụ ntutu n'ofe isi niile.

Ụdị ntutu isi nwoke na-eme ka ọ bụrụ n'ihi njikọta nke mkpụrụ ndụ ihe nketa na androgen, karịsịa dihydrotestosterone (DHT). Ihe kpatara ntutu isi ụmụ nwanyị ka dịtụghị anya.

Ọgwụgwọ a na-ahụkarị gụnyere minoxidil, finasteride, dutasteride, ma ọ bụ ịwa ahụ maka ịtụgharị ntutu. Iji finasteride na dutasteride mee ihe n'ime ụmụ nwanyị dị ime nwere ike ịkpata nkwarụ ọmụmụ.

Ọgwụgwọ
Finasteride na dutasteride kacha dị irè maka ụmụ nwoke na ụmụ nwanyị postmenopausal. Enwere ike iji obere minoxidil n'ọnụ, na-enye obere dose maka nhọrọ ụfọdụ.
#Finasteride
#Dutasteride

Ọgwụgwọ ― OTC Ọgwụ
N'ọtụtụ mba, a na-enweta minoxidil n'elu ụlọ ahịa. Enwere ụfọdụ mgbakwunye na-ekwu na ọ dị irè megide ntutu isi, mana ọtụtụ egosighi sayensị na ọ dị irè.
#5% minoxidil
☆ AI Dermatology — Free Service
Na nsonaazụ Stiftung Warentest nke 2022 sitere na Germany, afọ ojuju ndị ahịa na ModelDerm dị ntakịrị ntakịrị karịa na nyocha telemedicine akwụ ụgwọ.
  • Male-pattern hair loss (Ntutu dara n'ahụ nwoke)
    References Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics 34741573 
    NIH
    Although topical minoxidil, oral finasteride, and low‐level light therapy are the only FDA‐approved therapies to treat AGA, they are just a fraction of the treatment options available, including other oral and topical modalities, hormonal therapies, nutraceuticals, PRP and exosome treatments, and hair transplantation.